Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pre-B-cell leukemia homeobox 1
(
PBX1
) was originally identified as a proto-oncogene in human
leukemia
. Although this protein has been shown to contribute to cellular development and tumorigenesis, the role of
PBX1
in gastric carcinoma (GC) remains unclear. In this study, we observed increased expression of
PBX1
in GC tissues compared with adjacent normal tissues. This increase in
PBX1
expression levels negatively correlated with HOXB9 mRNA expression and was also associated with malignancy and metastasis.
PBX1
promoted proliferation and metastasis of GC cells both in vitro and in vivo.These phenomena were also accompanied by epithelial-to-mesenchymal transition (EMT). Additionally, we observed that
PBX1
promotes the expression of tumor growth and angiogenic factors. A structural model of the
PBX1
-HOX complex revealed that hydrophobic binding between
PBX1
and the hexapeptide motif might be required for EMT induction. This analysis also demonstrated that the Phe252 residue in the first helix of the TALE homeodomain is involved in the latter hydrophobic binding reaction. In vitro data from
PBX1
mutants suggest that
PBX1
cannot promote tumorigenesis of GC cells via EMT induction when Phe252 residues lose hydrophobicity. It is likely that the presence of this residue is essential in facilitating hydrophobic binding with the hexapeptide motif. These findings suggest that
PBX1
may be a potential target for GC treatment and this study provides a platform to elucidate the molecular mechanisms that underpin the role of
PBX1
in GC tumorigenesis.
...
PMID:A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma. 2851 54